Advertisement

Cardiac Arrhythmias After Cardiac Resynchronization

  • S. Serge Barold
  • Bengt Herweg

Keywords

Right Ventricular Cardiac Resynchronization Therapy Action Potential Duration Biventricular Pace Polymorphic Ventricular Tachycardia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gasparini M, Auricchio A, Regoli F, et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol. 2006;48:734–43.PubMedCrossRefGoogle Scholar
  2. 2.
    Hugl B, Bruns HJ, Unterberg-Buchwald C, et al. Atrial fibrillation burden during the post-implant period after crt usingdevice-based diagnostics. J Cardiovasc Electrophysiol 2006;17:813–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Hoppe UC, Casares JM, Eiskjaer H, et al. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure. Circulation 2006;114:18–25.PubMedCrossRefGoogle Scholar
  4. 4.
    Fung JW, Yu CM, Chan JY, et al. Effects of cardiac resynchronization therapy on incidence of atrial fibrillation in patients with poor left ventricular systolic function. Am J Cardiol 2005;96:728–31.PubMedCrossRefGoogle Scholar
  5. 5.
    Kies P, Leclercq C, Bleeker GB, et al. Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm. Heart 2006;92:490–4.PubMedCrossRefGoogle Scholar
  6. 6.
    Higgins SL, Yong P, Sheck D, et al. Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. Ventak CHF Investigators. J Am Coll Cardiol 2000;36:824–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Cleland JG, Daubert JC, Erdmann E, et al.; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539–49.PubMedCrossRefGoogle Scholar
  8. 8.
    Cleland JG, Daubert JC, Erdmann E, et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extensionphase]. Eur Heart J 2006;27: 1928–32.PubMedCrossRefGoogle Scholar
  9. 9.
    Rivero-Ayerza M, Theuns DA, Garcia-Garcia HM, Boersma E, Simoons M, Jordaens LJ. Effects of cardiac resynchronization therapy on overall mortality and mode ofdeath: a meta-analysis of randomized controlled trials. Eur Heart J 2006;27:2682–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Bristow MR, Saxon LA, Boehmer J, et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140–50.PubMedCrossRefGoogle Scholar
  11. 11.
    Desai AD, Burke MC, Hong TE, et al. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2006;17:486–90.PubMedCrossRefGoogle Scholar
  12. 12.
    Wilkoff BL, Hess M, Young J, Abraham WT. Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. J Cardiovasc Electrophysiol 2004;15:1002–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Ypenburg C, van Erven L, Bleeker GB, et al. Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias. J Am Coll Cardiol 2006;48:464–70.PubMedCrossRefGoogle Scholar
  14. 14.
    Moss AJ, Zareba W, Hall WJ, et al.; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877–83.PubMedCrossRefGoogle Scholar
  15. 15.
    Bardy GH, Lee KL, Mark DB, et al.; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225–37.PubMedCrossRefGoogle Scholar
  16. 16.
    Voigt A, Barrington W, Ngwu O, Jain S, Saba S. Biventricular pacing reduces ventricular arrhythmic burden and defibrillator therapies in patients with heart failure. Clin Cardiol 2006;29:74–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Arya A, Haghjoo M, Dehghani MR, et al. Effect of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in patients with an implantable cardioverter-defibrillator. Heart Rhythm 2005;2:1094–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Ermis C, Seutter R, Zhu AX, et al. Impact of upgrade to cardiac resynchronization therapy on ventriculararrhythmia frequency in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 2005;46:2258–63.PubMedCrossRefGoogle Scholar
  19. 19.
    Zagrodzky JD, Ramaswamy K, Page RL, et al. Biventricular pacing decreases the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy. Am J Cardiol 2001;87:1208–10.PubMedCrossRefGoogle Scholar
  20. 20.
    Kowal RC, Wasmund SL, Smith ML, et al. Biventricular pacing reduces the induction of monomorphic ventricular tachycardia: a potential mechanism for arrhythmia suppression. Heart Rhythm 2004;1:295–300.PubMedCrossRefGoogle Scholar
  21. 21.
    Kies P, Bax JJ, Molhoek SG, et al. Effect of cardiac resynchronization therapy on inducibility of ventricular tachyarrhythmias in cardiac arrest survivors with either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2005;95:1111–4.PubMedCrossRefGoogle Scholar
  22. 22.
    McSwain RL, Schwartz RA, DeLurgio DB, Mera FV, Langberg JJ, Leon AR. The impact of cardiac resynchronization therapy on ventricular tachycardia/fibrillation: an analysis from the combined Contak-CD and InSync-ICD studies. J Cardiovasc Electrophysiol 2005;16:1168–71.PubMedCrossRefGoogle Scholar
  23. 23.
    Fish JM, Brugada J, Antzelevitch C. Potential proarrhythmic effects of biventricular pacing. J Am Coll Cardiol 2005;46:2340–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Antzelevitch C, Oliva A. Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes. J Intern Med 2006;259:48–58.PubMedCrossRefGoogle Scholar
  25. 25.
    Antzelevitch C. Cardiac repolarization. The long and short of it. Europace 2005; 7:Suppl 2:3–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Antzelevitch C. Modulation of transmural repolarization. Ann N Y Acad Sci 2005; 1047:314–23.PubMedCrossRefGoogle Scholar
  27. 27.
    Antzelevitch C. Cellular basis and mechanism underlying normal and abnormal myocardial repolarization and arrhythmogenesis. Ann Med 2004;36(Suppl 1): 5–14.PubMedCrossRefGoogle Scholar
  28. 28.
    Fish JM, Di Diego JM, Nesterenko V, Antzelevitch C. Epicardial activation of left ventricular wall prolongs QT interval and transmural dispersion of repolarization: implications for biventricular pacing. Circulation 2004;109:2136–42.PubMedCrossRefGoogle Scholar
  29. 29.
    Medina-Ravell VA, Lankipalli RS, Yan GX, et al. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes? Circulation 2003;107:740–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Di Cori A, Bongiorni MG, Arena G, et al. New-onset ventricular tachycardia after cardiac resynchronization therapy. J Interv Card Electrophysiol 2005;12:231–5.PubMedCrossRefGoogle Scholar
  31. 31.
    Guerra JM, Wu J, Miller JM, Groh WJ. Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade. J Cardiovasc Electrophysiol 2003;14:1245–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Mykytsey A, Maheshwari P, Dhar G, et al. Ventricular tachycardia induced by biventricular pacing in patient with severe ischemic cardiomyopathy. J Cardiovasc Electrophysiol 2005;16:655–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Bortone A, Macia JC, Leclercq F, Pasquie JL. Monomorphic ventricular tachycardia induced by cardiac resynchronization therapy in patient with severe nonischemic dilated cardiomyopathy. Pacing Clin Electrophysiol 2006;29:327–30.PubMedCrossRefGoogle Scholar
  34. 34.
    Turitto G, Haq S, Benson D, El-Sherif N. Torsade de pointes: an electrophysiological effect of cardiac resynchronization? Pacing Clin Electrophysiol 2006;29:520–2.PubMedCrossRefGoogle Scholar
  35. 35.
    Rivero-Ayerza M, Vanderheyden M, Verstreken S, de Zutter M, Geelen P, Brugada P. Images in cardiovascular medicine. Polymorphic ventricular tachycardia induced by left ventricular pacing. Circulation 2004;109:2924–5.PubMedCrossRefGoogle Scholar
  36. 36.
    Shukla G, Chaudhry GM, Orlov M, Hoffmeister P, Haffajee C. Potential proarrhythmic effect of biventricular pacing: fact or myth? Heart Rhythm 2005;2:951–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Tanabe Y, Chinushi M, Washizuka T, et al. Suppression of electrical storm by biventricular pacing in a patient with idiopathic dilated cardiomyopathy and ventricular tachycardia. Pacing Clin Electrophysiol 2003;26:101–2.PubMedCrossRefGoogle Scholar
  38. 38.
    Harada M, Osaka T, Yokoyama E, Takemoto Y, Ito A, Kodama I. Biventricular pacing has an advantage over left ventricular epicardial pacing alone to minimize proarrhythmic perturbation of repolarization. J Cardiovasc Electrophysiol 2006;17:151–6.PubMedCrossRefGoogle Scholar
  39. 39.
    Berger T, Hanser F, Hintringer F, et al. Effects of cardiac resynchronization therapy on ventricular repolarization in patients with congestive heart failure. J Cardiovasc Electrophysiol 2005;16:611–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Bai R, Yang XY, Song Y, et al. Impact of left ventricular epicardial and biventricular pacing on ventricular repolarization in normal-heart individuals and patients with congestive heartfailure. Europace 2006;8:1002–10.PubMedCrossRefGoogle Scholar
  41. 41.
    van Huysduynen BH, Swenne CA, Bax JJ, et al. Dispersion of repolarization in cardiac resynchronization therapy. Heart Rhythm 2005;2:1286–93.PubMedCrossRefGoogle Scholar
  42. 42.
    Chalil S, Yousef ZR, Muyhaldeen SA, et al. Pacing-induced increase in QT dispersion predicts sudden cardiac death following cardiac resynchronization therapy. J Am Coll Cardiol 2006;47:2486–92.PubMedCrossRefGoogle Scholar
  43. 43.
    Garrigue S, Barold SS, Hocini M, Jais P, Haissaguerre M, Clementy J. Treatment of drug refractory ventricular tachycardia by biventricular pacing. Pacing Clin Electrophysiol 2000;23:1700–2.PubMedCrossRefGoogle Scholar
  44. 44.
    Byrd IA, Rogers JM, Smith WM, Pollard AE. Comparison of conventional and biventricular antitachycardia pacing in a geometrically realistic model of the rabbit ventricle. J Cardiovasc Electrophysiol 2004;15:1066–77.PubMedCrossRefGoogle Scholar
  45. 45.
    Kuhlkamp V; InSync 7272 ICD World Wide Investigators. Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy. J Am Coll Cardiol 2002;39:790–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Fernandez Lozano I, Higgins S, Escudier Villa JM, et al. Antitachycardia pacing efficacy significantly improves with cardiac resynchronization therapy. Rev Esp Cardiol 2005;58:1148–54.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • S. Serge Barold
  • Bengt Herweg

There are no affiliations available

Personalised recommendations